Macrophage polarization regulation shed lights on immunotherapy for CaOx kidney stone disease

• Published in: Biomedicine & pharmacotherapy 2024-10, Vol.179, p.117336, Article 117336
• Main Authors: Zhu, Wang, Qiong, Deng, Changzhi, Xu, Meiyu, Jin, Hui, Liang
• Format: Article
• Language: English
• Subjects: Macrophage; Metabolism; Nephrolithiasis; Polarization
• ISSN: 0753-3322; 1950-6007; 1950-6007
• DOI: 10.1016/j.biopha.2024.117336

Kidney stone disease (KSD) is a major public health concern associated with high morbidity and recurrence, places a significant burden on the health care system worldwide. Calcium oxalate (CaOx) alone or a mixture of CaOx and calcium phosphate stones accounting for more than 80 % of cases. However, beyond surgical removal, the prevention and reduction of recurrence of CaOx kidney stones have always been a challenge. Given that macrophages are traditional innate immune cells that play critical roles in the clearance of pathogens and the maintenance of tissue homeostasis, which have gained more and more interests in nephrolithiasis. Several studies recently clearly demonstrated that M2-macrophage could reduce the renal calcium oxalate (CaOx) crystal acumination, and provide premise insights and therapeutic options for KSD by modulating the macrophage phenotypes. However, the mechanism of macrophage-polarization regulation and that effects on kidney stone prevention and treatments are far from clear. Here, we comprehensively reviewed the literatures related to cytokines, epigenetic modifications and metabolic reprograming of macrophage in CaOx kidney stone disease, aimed to provide better understandings on macrophage polarization regulation as well as its potential clinical applications in CaOx kidney stone disease treatments and prevention. [Display omitted] •Both KRMs and IMs play a crucial role in kidney stone formation.•Macrophage polarization can be modulated by cytokines, epigenetic modifications and reprogramming of intracellular metabolisms.•Macrophage phenotype alteration offered new insights and treatment options for kidney stone disease.